Home >> Pharmaceuticals >> Food & Beverage >>

Global Preventive Asthma Drugs Market 2015-2019

Published: Oct-2015 | Format: PDF | Technavio | Number of pages: 81 | Code: MRS - 35342

About asthma

According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The symptoms worsen due to the increased secretion of mucus, bronchoconstriction, and thickening of the walls of the airways, resulting in difficulty in expiration. According to the American Academy of Allergy, Asthma, and Immunology, asthma is classified into four types: exercise-induced, allergic, occupational, and childhood. Also, asthma can be classified into two categories: allergic and non-allergic, as per the classification of Asthma and Allergy Foundation of America. Asthma can be managed by preventive medications, which should be administered to the patient regularly to improve his quality of life by controlling the exacerbations.

Technavio's analysts forecast the global preventive asthma drugs market to grow at a CAGR of 5.20% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global preventive asthma drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of the following classes of drugs used to treat asthma:
• Immunosuppressants 
• Leukotriene antagonists
• Mast cell stabilizers
• Corticosteroids
• Combination of LABA/ ICS

This report includes a discussion of the market in the following three regions: 
• Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
• EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
• APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India

Technavio's report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. 

Key regions
• Americas
• APAC
• EMEA

Key vendors
• AstraZeneca
• F. Hoffmann-La Roche
• GlaxoSmithKline 
• Merck
• Novartis 

Other prominent vendors
• Abbott
• Amgen
• AptarGroup
• Biotest
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cytos
• Dainippon Sumitomo
• Medicinova
• Mylan
• Novartis
• Orchid Chemicals and Pharmaceuticals
• Pfizer
• Rottapharm Madaus
• Skyepharma
• Sosei
• Sunovion
• Teva Pharmaceutical 
• Theravance
• Vectura  

Key market driver
• High prevalence of asthma
• For a full, detailed list, view our report

Key market challenge
• Unknown disease etiology 
• For a full, detailed list, view our report

Key market trend
• Growing popularity of combination therapies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be
• What are the key market trends
• What is driving this market
• What are the challenges to market growth
• Who are the key vendors in this market space
• What are the market opportunities and threats faced by the key vendors
• What are the strengths and weaknesses of the key vendors
PART 01: Executive summary
 Highlights

PART 02: Scope of the report
 Market overview
 Top-vendor offerings

PART 03: Market research methodology
 Research methodology
 Economic indicators

PART 04: Introduction
 Key market highlights

PART 05: Product profiles
 Accolate
 Pulmicort
 Symbicort
 Xolair
 Advair
 Anoro Ellipta
 Arnuity Ellipta
 Breo Ellipta
 Flovent
 Serevent
 Ventolin
 Asmanex
 Foradil
 Dulera
 Singulair

PART 06: Disease overview
 Understanding the disease
 Symptoms
 Pathophysiology
 Epidemiology
 Diagnosis
 Management

PART 07: Pipeline Portfolio

PART 08: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis

PART 09: Market segmentation by class of drug

PART 10: ICS/LABA  combination
 Global ICS/LABA  combination market

PART 11: Immuno-suppressants
 Global immunosuppressants market

PART 12: Leukotriene antagonists
 Global leukotriene antagonists market

PART 13: Mast cell stabilizers
 Global mast cell stabilizers market

PART 14: Inhaled corticosteroids
 Global inhaled corticosteroids market

PART 15: Geographical segmentation
 Global preventive asthma drugs market by geography 2014-2019
 Preventive asthma drugs market in Americas
 Preventive asthma drugs market in EMEA
 Preventive asthma drugs market in APAC

PART 16: Market drivers

PART 17: Impact of drivers

PART 18: Market challenges

PART 19: Impact of drivers and challenges

PART 20: Market trends

PART 21: Vendor landscape
 Competitive scenario
 Other and future prominent vendors

PART 22: Key vendor analysis
 AstraZeneca
 F. Hoffmann-La Roche
 GlaxoSmithKline
 Merck
 Novartis

PART 23: Appendix
 List of abbreviations

PART 24: Explore Technavio
? 
 List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Major diagnostic procedures for asthma
Exhibit 03: Major drugs under development for asthma
Exhibit 04: Global preventive asthma drugs market ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global preventive asthma drugs market by class of drug
Exhibit 07: Segmentation of global preventive asthma drugs market by class of drug 2014
Exhibit 08: Global preventive asthma drugs market: Market share by class of drug 2014-2019 ($ millions)
Exhibit 09: Global ICS/LABA combination market 2014-2019 ($ millions)
Exhibit 10: Global immunosuppressants market 2014-2019 ($ millions)
Exhibit 11: Global leukotriene antagonists market 2014-2019 ($ millions)
Exhibit 12: Global mast cell stabilizers market 2014-2019 ($ millions)
Exhibit 13: Global corticosteroids market 2014-2019 ($ millions)
Exhibit 14: Global preventive asthma drugs market by geography 2014
Exhibit 15: Global preventive asthma drugs market: Market share by region 2014-2019 ($ millions)
Exhibit 16: Preventive asthma drugs market in Americas 2014-2019 ($ millions)
Exhibit 17: Preventive asthma drugs market in EMEA 2014-2019 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Sales of Pulmicort in US 2011-2014 ($ millions)
Exhibit 21: Global sales of Pulmicort 2011-2014 ($ millions)
Exhibit 22: AstraZeneca: Key takeaways
Exhibit 23: Sales of Xolair in the US 2011-2014 ($ millions)
Exhibit 24: F. Hoffmann-La Roche: Key takeaways
Exhibit 25: Global sales of Ventolin 2011-2014 ($ millions)
Exhibit 26: Global sales of Flovent 2011-2014 ($ millions)
Exhibit 27: Global sales of Advair 2011-2014 ($ millions)
Exhibit 28: Global sales of Serevent 2011-2014 ($ millions)
Exhibit 29: GlaxoSmithKline: Key takeaways
Exhibit 30: Global sales of Asmanex 2011-2013 ($ millions)
Exhibit 31: Global sales of Dulera 2011-2013 ($ millions)
Exhibit 32: Global sales of Singulair 2011-2013 ($ millions)
Exhibit 33: Merck: Key takeaways
Exhibit 34: Sales of Xolair (ex-US) 2011-2014 ($ millions)
Exhibit 35: Key takeaways: Novartis
Exhibit 36: AstraZeneca: Business segmentation by revenue 2014
Exhibit 37: AstraZeneca: Business segmentation by revenue 2013 and 2014
Exhibit 38: AstraZeneca: Geographical segmentation by revenue 2014

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing